Abstract: Objective The production of neurotoxic β-amyloid and the formation of hyperphosphorylated tau are thought to be critical steps contributing to the neuropathological mechanisms in Alzheimer's disease (AD). However, there remains an argument as to their importance in the onset of AD. Recent studies have shown that axonopathy is considered as an early stage of AD. However, the exact relationship between axonopathy and the origin and development of classic neuropathological changes such as senile plaques (SPs) and neurofi brillary tangles (NFTs) is unclear. The present study aimed to investigate this relationship. Methods Postmortem tracing, combined with the immunohistochemical or immunofl uorescence staining, was used to detect axonopathy and the formation of SPs and NFTs. Results "Axonal leakage"-a novel type of axonopathy, was usually accompanied with the extensive swollen axons and varicosities, and was associated with the origin and development of Aβ plaques and hyperphosphorylated tau in the brains of AD patients. Conclusion Axonopathy, particularly axonal leakage, might be a key event in the initiation of the neuropathological processes in AD.
Introduction
Alzheimer's disease (AD) is a debilitating neurodegenerative disease and is the most common form of dementia. The pathological hallmarks of AD are senile plaques (SPs) and neurofibrillary tangles (NFTs), which are potentially linked to alterations of the axonal compartment. SPs are mainly composed of β-amyloid (Aβ) and dystrophic neuritis. Some dystrophic neuritis correspond to axonal swellings, which often contain abnormal accumulations of axonal cargos and phosphorylated tau [1] . NFTs are related to the abnormal phosphorylation of the microtubule-associated protein tau and its subsequent dislocation from axons to the presynaptic terminals and somatodendritic compartments [2] . Although neurotoxic Aβ deposition and the formation of hyperphosphorylated tau are thought to be critical steps involved in the neuropathological mechanisms of AD, a debate still exists over whether SPs or NFTs play a key and causal role in the neuropathological mechanisms of AD. Much effort has been made to find a direct neuropathological relationship between SPs and NFTs or to look for additional evidence supporting an alternative proposal that both SPs and NFTs may be the results of neuropathological changes, not the causes of AD.
However, there is currently no consensus on this issue [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] .
The biological function of a neuron is highly dependent on an intact axon through which axonal transport and neural signals are supported [15, 16] . In AD, obvious axonopathy mainly manifests as impairment of axonal transport and swelling of the axon and varicosity [17] [18] [19] [20] [21] . Such axon defects have been shown to precede known disease-related pathology in mouse models of AD, and are considered as early stages of AD [19] . A previous study has found that the decrease in axonal transport in the cortical neurons in AD is related to the degree of the classic neuropathological changes, SPs and NFTs [17] . Axonal transport impairment and the swelling of axons and varicosities have also been observed both in living AD patients and in animal models [21] [22] [23] [24] [25] [26] [27] .
Although these studies imply that axonopathy plays an important and early role in the neuropathological mechanisms of AD, it remains still unclear whether axonopathy is an independent neuropathological change parallel to the formation of SPs and NFTs, or whether it plays an additional role in AD. In a preliminary study [28] , we identifi ed a new type of axonopathy named "axonal leakage" in AD. The present study aimed to investigate its relationship with the origin and formation of SPs and NFTs in AD.
Materials and methods

Human brain materials Human brain tissues were
obtained from the Netherlands Brain Bank (NBB). According to the protocol of the NBB, specifi c permission for brain autopsy and use of the brain tissue and the medical records for research purpose was given by the patients or their partners/relatives. AD was clinically diagnosed based on the criteria of the National Institute of Neurological and Communication Disorders and the Stroke-Alzheimer's disease and Related Disorders Association [29] . The diagnosis of "probable AD" was established by excluding other causes of dementia. Brains from AD patients and controls were systematically neuropathologically investigated. Neuropathological changes in AD were scored using the staging system of Braak [30] . The clinical diagnosis of "probable AD" was confi rmed by a Braak score of IV or more, while non-demented aged and other subjects were at Braak stages 0-II.
A total of 39 postmortem human brains were collected for the present study, 26 of which were from people with AD. The clinical and neuropathological data of the subjects were listed in Table 1 . The average age and postmortem delay were 83.7 years and 4:09 (hours:minutes)
for AD, and 67.8 years and 9:03 for no-demented subjects, respectively. Following removal of the brain, standardized samples of gyrus from the anterior part of the medial frontal cortex (FC, equivalent to Broca's area 9), medial temporal cortex (TC, equivalent to Broca's area 21), occipital cortex (OC, equivalent to Broca's area 7) and hippocampus were dissected. The cortex samples were trimmed into slices (0.40.6 cm thick) containing the cortical layers and 1.5-2.0 cm white matter. The hippocampus was cut into coronal slices (0.40.6 cm thick) containing dentate gyrus, C1-C4 regions and part of the entorhinal cortex.
Postmortem tracing in human brain slices
Postmortem tracing for human brain tissue has been described in a previous study [31] . Briefl y, the prepared brain slice was immediately incubated in modifi ed artifi cial cerebrospinal 
Double immunohistochemical and immunofluorescence staining
The double staining combining tracer detection with immunocytochemistry was performed according to the procedures described previously [31] . After . Cross-reactivity was tested by omitting the secondary antibodies for immunostaining, and no staining was detected.
Electron microscopy A pre-embedding tracer detec-
tion technique was used to demonstrate the subcellular distribution of tracer as described before [32] . vere, more than moderate [17] . (Table 1 ). As shown in Fig. 1A -C, swollen axons and varicosities were observed in brain areas affected by AD as reported earlier [19] . Unexpectedly, in AD brains, tracer staining was observed around certain areas of swollen axons, or around the edges of swollen varicosities (Fig. 1A-C) , while the morphology of the labeled fibers was almost normal in young control brains (Fig. 1D ) and in postmortem rat brains [31] . This axonal change was named "axonal leakage", a new type of axonopathy [28] . Fig. 2A and Fig. 2B present the typical instances of swollen axons and varicosities, and axonal leakage at the light microscopic level, respectively. The theoretical explanation of axonal leakage identifi cation using this tracing technique and the use of this terminology is provided in Fig. 3 .
Quantitative
Sections displaying axonal leakage were selected by light microscopy and were further examined under the electron microscope. In leaking axons, the staining for tracer (a dot-like configuration) was observed in the intra-axonal and extra-axonal spaces and even in the myelin sheath (Fig. 4A) , while in intact axons, the staining was only restricted to the intra-axonal space (Fig. 4B ). labeled fi bers [17] thus affecting the number of instances of in TC from AD subjects, also with no signifi cant difference (P = 0.785). However, the number of instances of axonal leakage in TC was significantly larger than that in FC in AD subjects (P = 0.008) (Fig. 5A , Table 2 ). This might be related to the neuropathological changes such as SPs and NTFs, as SPs and NFTs were denser in TC than in FC (Table 2). In contrast, the mean number of instances of axonal leakage was not signifi cantly different between FC and TC in non-demented control subjects (P = 0.094) (Fig. 5A ). and immunofl uorescence staining for tracer and Aβ (Aβ42), P-tau, tau-5 or AT8 were performed. As shown in Fig. 6 , Aβ42 and hyperphosphorylated tau staining were located within and/or close to the swollen axons, varicosities or SPs and NFTs were scored as none (0), sparse/slight (1), moderate (2) or frequent/severe (3). AL: axonal leakage (mean ± SE); SPs: senile plaques; NFTs: neurofi - (Fig. 7) . Interestingly, normal fi bers or terminals labeled by tracer were detectable in the plaques in the brains of AD patients (Fig. 6J-L) . 
Degrees of axonal leakage in frontal and
The relationship between axonal leakage and classical neuropathological changes
Discussion
The in vitro postmortem tracing technique has been used to study hypothalamic neural circuits (neural connections) and axonal transport in human brains [17, 18, 31] . In the present study, the use of this technique in human brain materials was extended to analyze changes in axon morphology, which are related to the neuropathological mechanisms underlying AD. With proper in vitro treatment, human brain cells, even those with a postmortem delay of up to 10 h, can survive to an extent that they still have the potential of recovering axonal transport [31] and present axon morphology similar to that observed by in vivo tracing techniques. In addition, the tissue fi xation used in the present study did not result in obvious changes in axon morphology. Therefore, the observed axonal changes were not an artifact due to the relatively long incubation time (up to 68 h) or tissue fi xation used during in vitro postmortem tracing. It should be emphasized that the cause of death, mostly pneumonia, cachexia and dehydration in AD, may not be the main cause of axonal leakage, since axon morphology is quite normal in some brain areas such as visual cortex in most AD cases, although evident axonal changes, including axonal leakage, occur in TC and FC.
In the present study, we investigated axonal leakage in the brains of AD patients, and analyzed its relationship with the classic neuropathologcal changes, SPs and NFTs. Stokin et al. have revealed that axonal swellings are precursors in AD, and that they precede amyloid deposits and other disease-related neuropathies [19] . Our fi ndings are consistent with that report. Together with previous findings, our data suggest that axonal leakage may be an important initial neuropathological change leading to the origin and development of the classic neuropathies, SPs and NFTs, as well as cognitive defects in AD. Although the detailed mechanism of how axonal leakage results in the formation and development of SPs and NFTs needs to be investigated, the possible explanations are as follows. Direct leakage of intra-axonal components, including structural and functional proteins, to extra-axonal space may be partly involved in the formation of plaques. For example, the leakage of overproduced intra-axonal Aβ or extra-axonal proteolysis of the leaked amyloid precursor protein may result in Aβ plaques [33] , which may explain the Aβ plaques observed in brain areas with unimpaired neural functions [2, 11] . Axonal leakage may be present at axon areas. Such an explanation is supported by our fi nding that intact neural fi bers were present in or around the plaques (Fig. 6J-L) . We also observed degenerating neuronal fi bers around the plaques, which is similar to the previous fi ndings (Fig. 6K, L) . This is probably because these fibers arise from affected neurons, although we cannot exclude the possibility that this may be due to the neurotoxic effects of Aβ [6, 24, 34] . In another study, Meyer-Luehmann et al. demonstrated in a mouse model of AD that plaques can grow overnight, with mature plaques originating from smaller amyloid deposits (microplaques) associated with alterations in neighboring neurites [35] . The origin of the microplaques is unclear, but our recent fi ndings suggest that they might be related to axonal leakage.
Axonal leakage may result in an abnormal change in intra-axonal Ca 2+ concentration due to uncontrolled direct diffusion from extra-axonal to intra-axonal space. This may induce tau hyperphosphorylation through activation of a Ca 2+ -dependent enzyme, a key step in the formation of NFTs [36, 37] . This explanation is supported by our fi nding that hyperphosphorylated tau staining occured in certain segments of a relatively normal axon. In this situation, axonal leakage may be at an early and reversible stage. This also suggests that NFTs originate earlier than SPs [5, 11, 38, 39] .
Our findings also provide a better understanding of the relationship between the AD-related risk factors and the neuropathies of this disease. Axonal leakage is likely due to alterations in the axonal membrane and myelin sheath. Therefore, we propose that AD-like neuropathological changes and cognitive deficits might be expected if any of the risk factors such as mitochondrial dysfunction, abnormal metabolism and oxidative stress affects the membrane stability and consequently induces severe axonal leakage [18, 40, 41] . Although the cellular and molecular mechanisms underlying the origin and development of axonal leakage are not yet understood, disruption in the function of oligodendrocytes (including their precursor cells) as well as their integration with neurons and astrocytes may play an important role [42] . Therefore, reducing axonal leakage by stabilizing, strengthening and enriching the neuronal membrane and myelin sheath may provide a new strategy for prevention of AD, as well as a potential therapy for this disease.
